Etoposide Completed Phase 2 Trials for Brain and Central Nervous System Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003621Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma
NCT00003309Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer
NCT00002876Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas
NCT00004224Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma
NCT00003996Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00006258Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma